Regarding specific studies of GBM, Morimoto et al. (2021) [386] separately tested the knockout of two exons of the TIM3 gene in primary human NK cells, via the electroporation of the Cas9-guided RNA ribonucleoprotein complex. The gene discussed is HAVCR2; the disease is glioblastoma.